Background
Cancer, breast, colorectal, and/or prostate, cancer, corona virus disease, chronic disease
CANCER, CHRONIC DISEASES, CHRONIC DISEASE, CANCER
Cancer and chronic diseases are a major cost to the healthcare system [The BETTER trial developed an approach to primary prevention and screening for cancer and chronic disease [The previous BETTER trial [The primary objective was to determine if patients 40–65 years of age, including cancer survivors (breast, colorectal, and/or prostate), randomized to receive the BETTER approach which included an individualized prevention visit with a PP, had improved general prevention and screening outcomes and cancer surveillance 12 months after the initial prevention visit as compared to standard care in a wait-list control group. During the trial, the corona virus disease (COVID-19) resulted in a public health state of emergency being declared in Alberta, Newfoundland & Labrador, and Ontario in March 2020 resulting in all non-essential services being closed. The aim of this paper is to present the results of the BETTER WISE trial, specifically the 12-month prevention and screening outcomes, and to describe how the trial was impacted by the COVID-19 pandemic [